Full-Time
Principal Corevalve Therapy Development Specialist
Multiple Teams
Posted on 9/23/2025
Medtronic
10,001+ employees
Medical device maker advancing therapies
Compensation Overview
$140k - $150k/yr
Orlando, FL, USA
In Person
 Medical, Clinical & Veterinary (2) |
|---|
| , |
- A High School Diploma plus 11+ OR Associate’s Degree and 9 + OR Bachelor’s degree and 7+ years clinical or sales experience; selling or supporting interventional cardiology, vascular or surgical products, with at least 3 years’ of such experience in an industry setting.
- Provide quality technical support to help sites achieve procedural success
- Provide technical support to Medtronic employees and implanting teams for CoreValve implant procedures in accordance with Medtronic guidance
- Provide technical leadership for TAVR device procedures
- Educate implanting teams on proper indications for TAVR procedures
- Provide support on questions regarding device suitability with measuring ability and CT reconstruction expertise
- Provide comprehensive technical support including knowledge of imaging modalities (echo/angiography/CT), EKG, blood pressure, wave forms, and ancillary procedural solutions
- Develop and maintain comprehensive clinical and technical product knowledge
- Oversee local education and training activities including coordination and set up procedure simulators
- Provide education on safe and effective use of Medtronic products
- Support district sales strategy working with sales representatives and managers to achieve business plans within CBT business unit and broader CVG organization
- Ensure comprehensive technical and customer support within territory to maintain superior customer service levels and effective time management
- Assist with customer management of inventory ordering, shelf stock, and returns
- Identify, establish and maintain productive working relationships with key decision makers, customers and their staff
- Participates in customer/society education meetings and conventions
- Respond to customer requests and resolve complaints in a prompt and effective manner
- Report and device complaints to proper departments within quality assurance within Medtronic
- Help drive and maintain quality initiatives and global best practice initiatives
- Maintain high standards of personal presentation and promote a professional personal and company image
- Assist in training new hires to Medtronic CBT team
- Submit accurate and timely expense reports
- Schedule travel arrangements to ensure multiple objectives are accomplished
- Maintain hospital eligibility/access with various vendor credentialing services
- Maintain a high level of communication with appropriate CVG sales and leadership within assigned geography
- Communicate market intelligence/competitor activity promptly, including potential sales leads, and information regarding product price or account activity to District Manager and other appropriate company personnel
- Ensure a professional standard of written and verbal communication at all times
- Associate’s Degree in engineering, nursing, or the sciences
- Bachelor’s Degree in business or science
- Experience with wires, balloons, catheters, stents
- Exceptional understanding of cardiac and vascular anatomy, physiology, and pathology
- Experience communicating product’s market advantages to physicians and hospital administration
- Experience managing multiple accounts
- Experience teaching and educating medical personnel, peers and technical support personnel
- Imaging interpretation experience (TTE or Trans Esophageal Echocardiography (TEE), CT, Angiograms)
- Expertise with Microsoft Outlook, Excel, Word and PowerPoint
- Excellent influencing and consulting skills
- Excellent interpersonal and written communication skills
- Ability to make timely and sound decisions
- Strong project management skills with experience coordinating programs
- Thorough working knowledge of medical terminology, medical procedures and the medical device industry
- Excellent customer service skills
- Effectively build and maintain positive relationships with peers and colleagues across organizational levels and functions
- Ability to coordinate/participate in numerous tasks/projects in a fast-paced environment in an organized manner while meeting deadlines
- Excellent interpersonal, written and verbal communication skills
- Strong work ethic in accomplishing objectives of the position
- Ability to travel with overnight stay up to 50-75% of the time (geography variability)
Medtronic makes medical devices and therapies to treat chronic diseases, including implantables, sensors, and diabetes management tools. Its devices interact with the body to regulate or monitor functions, such as pacemakers delivering heart stimulation and neuromodulation devices sending electrical signals. The company differentiates itself through a long history of device development and a broad portfolio, expanded via acquisitions to access new technologies and markets. Its goal is to improve patient health outcomes by providing integrated medical technologies that help manage chronic conditions.
Company Size
10,001+
Company Stage
IPO
Headquarters
Fridley, Minnesota
Founded
1949
Simplify's Take
What believers are saying
- Sphere-9 catheter achieves 65.5% VT-free rate at six months, earning FDA Breakthrough Designation.
- Stealth AXiS gains CE mark for AI-powered navigation in spine and cranial procedures.
- 20M investment in Orchestra BioMed advances BACKBEAT hypertension trial commercialization.
What critics are saying
- ShinyHunters breach exposes 9M records, sparking lawsuits and eroding provider trust by Q3 2026.
- Santa Rosa closure cuts 370 jobs, disrupting cardiovascular innovation by spring 2028.
- MiniMed IPO spins out diabetes unit, slashing $5B revenue to Abbott's FreeStyle Libre.
What makes Medtronic unique
- Medtronic's Percept DBS system uses BrainSense technology for closed-loop adaptive stimulation.
- Percept automatically adjusts to Parkinson's symptom fluctuations like tremor and rigidity.
- FDA approved Medtronic's closed-loop DBS as milestone ahead of Abbott and Boston Scientific.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Employee Assistance Program
Wellness Program
Company News
Medtronic and GE HealthCare have launched a digital integration combining GE's bkActiv intraoperative ultrasound with Medtronic's Stealth AXiS surgical navigation system for cranial neurosurgery. The commercially available system provides real-time imaging during procedures, connecting Medtronic's navigation and robotics platforms with GE HealthCare's imaging technology. The integration aims to enhance clinical decision-making during complex cranial procedures through precise guidance and visualisation. It may influence hospital equipment purchasing decisions, surgeon productivity and operating room efficiency. Medtronic currently trades at $87.91, approximately 19.8% below the $109.64 analyst target range midpoint. The stock has experienced a 2.2% decline over the past 30 days. Adoption rates amongst surgeons and hospitals, alongside hospital capital spending on neurosurgery suites, will be key factors to monitor.
GE HealthCare has announced a digital integration between its bkActiv intraoperative ultrasound system and Medtronic's Stealth AXiS surgical navigation system, now commercially available for cranial procedures. The integration allows neurosurgeons to use bkActiv as a plug-and-play real-time visualisation solution during procedures. The system addresses "brain shift", a natural movement of the brain during surgery that reduces pre-surgical image accuracy. bkActiv provides live ultrasound images alongside pre-operative MRI or CT scans on the Stealth AXiS system, recently cleared by the FDA for cranial procedures in the United States. Features include sterilisable transducers, sensitive colour Doppler for blood flow visualisation, and remote control capability from the sterile field. The companies will showcase the integration at the American Association of Neurological Surgeons Annual Scientific Meeting in May 2026.
Stifel has lowered its price target on Medtronic (NYSE:MDT) to $95 from $105, maintaining a Hold rating. The adjustment reflects transaction-related impacts from the 9 March IPO of Medtronic's Diabetes business, now called MiniMed. MiniMed will remain a consolidated subsidiary until formal separation, expected about six months post-IPO. Stifel continues to model full Diabetes business revenue whilst adjusting for the 10% non-controlling interest sold in the IPO. Management expects IPO-related earnings per share dilution of 1-2 cents monthly until separation completes. Separately, the US Food and Drug Administration recently cleared Medtronic's Stealth AXiS surgical system for cranial and ear, nose and throat procedures, expanding beyond its earlier spine indication.
What impact might Medtronic's new lab have on Galway's medtech ecosystem? 3 Apr 2026 From left: Ruth Callanan, Ronan Rogers and John Caulfield. Image: Andrew Downes/Xposure Ronan Rogers and Ruth Callanan discuss innovation in the west of Ireland and the evolution of Ireland's STEM careers. Ireland's medtech sector is moving beyond traditional biomedical engineering, according to Ronan Rogers, the senior R&D director for cardiac ablation solutions at Medtronic. He explained the region has built "real depth", not just in medtech, but across key areas such as pharmaceutical science, advanced analytics and digital technology. Areas that are now "increasingly converging". "That diversity of opportunity is a huge strength for Ireland," he told SiliconRepublic.com. "It allows people from different professional backgrounds to find meaningful, high-impact careers in healthcare, while helping Ireland move further up the value chain as a centre for complex, globally relevant innovation." Having recently expanded its Galway-based pharmaceutical laboratory, the Medtronic facility now serves as a west of Ireland hub for high-tech innovation and the evolving needs of the global healthcare space. Rogers is of the opinion that this is reflective of the convergence of the country's medtech divisions. Noting that the primary purpose of the lab "is to integrate pharmaceutical, engineering and analytical expertise under one roof to address the complex challenges of combination products, [that is] where a medical device and a medicine work together". "We see that convergence very clearly in this laboratory and there is a wide range of career paths in our industry, whether that's a pharmacist drawn to the faster innovation cycles and applied science of medtech, or a software developer who wants to use their skills to solve real healthcare challenges and code with a deeper sense of purpose." What opportunities exist? With the expansion comes the opportunity for students and professionals to consider a new role, either as part of Medtronic or within Galway's thriving life science and medtech spaces. "Galway offers a unique innovation ecosystem where infrastructure, academic partnerships and a significant medtech footprint all provide a strong foundation for sustaining Ireland's leadership in the life sciences sector," said Ruth Callanan, Medtronic's director of site quality. With the investment focused on significantly expanding R&D capability and technical depth within a critical space in the Irish medtech sector, Medtronic has increased lab space by almost a half and introduced analytical technologies that didn't exist there before. Callanan said: "This creates the conditions for future high-value work as programmes grow. It strengthens Galway's ability to attract and retain highly specialised talent, pharmaceutical scientists, chemical and materials engineers and it allows work that was previously outsourced internationally to be done here in Ireland. "Over time, as demand and activity scale, we do expect this capability to support additional specialist roles, phased in over the coming years. Importantly, it reinforces Ireland's position at the forefront of advanced medtech R&D and reflects a broader industry trend toward self-sufficiency in high-tech analytical testing." Step into the future. She explained the new lab will enable experts to integrate processes as the facility will be responsible for the entire life cycle of product development, from early phase R&D through to post-market oversight. She added: "The laboratory utilises advanced LCMS [liquid chromatography-mass spectrometry] and GCMS [gas chromatography-mass spectrometry] technologies, which act as 'molecular microscopes'. This allows our scientists to identify unknown compounds or impurities at extremely precise levels." According to Rogers, the new lab has a role to play in what he believes to be the reshaping of how STEM careers in Ireland are perceived and pursued, with Callanan noting this creates for students and professionals opportunities to engage with careers that bridge the gap between various scientific disciplines. "A laboratory of this size and complexity requires students and professionals with a wide range of skills and experience across multiple disciplines," she said. "Just as importantly," added Rogers, "we're sending a clear signal to pharmacists, chemists and analytical scientists that medtech offers deep, intellectually challenging career paths that go well beyond traditional manufacturing or even classical biomedical engineering." Laura Varley is the Careers editor for Silicon Republic
Medtronic launches new pharmaceutical lab in Galway. A GLOBAL health tech leader which is headquartered in Galway has unveiled a new laboratory in the city. Medtronic has formally opened a new Pharma Laboratory and Building 6 at its location in Parkmore. Galway TD and Minister of State Seán Canney attended the launch event this month. Minister Seán Canney (centre) attended the opening of the new laboratory this month "Great to be in Parkmore to officially open the new Pharma Laboratory and Building 6 at Medtronic," he said. "This is a really significant investment for Galway and for the West - strengthening our position as a global leader in MedTech and supporting the next generation of innovation." He added: "The facility will act as a "one-stop shop" for testing and validating drug-device combination products - a fast-growing area that is improving outcomes for patients worldwide. "Medtronic has been part of Galway for over 40 years, and what's been built here is genuinely world-class. "It reflects the strength of the talent, the ecosystem, and the ambition that exists across this region. Most importantly, this is about impact - better treatments, better technologies, and better outcomes for patients. "A real vote of confidence in Galway and in Ireland." Everything from irishpost.com and the print edition is available on the Irish Post App - plus more! Download it for Android or Apple IOS devices today.